ClinVar Miner

Submissions for variant NM_000251.2(MSH2):c.1943T>A (p.Ile648Asn) (rs763100088)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000222363 SCV000278504 uncertain significance Hereditary cancer-predisposing syndrome 2016-08-15 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Insufficient evidence
GeneDx RCV000523371 SCV000618299 uncertain significance not provided 2017-03-12 criteria provided, single submitter clinical testing This variant is denoted MSH2 c.1943T>A at the cDNA level, p.Ile648Asn (I648N) at the protein level, and results in the change of an Isoleucine to an Asparagine (ATT>AAT). This variant has been reported in an individual with colon cancer reported to have microsatellite instability but normal immunohistochemistry (Poynter 2008). MSH2 Ile648Asn was not observed at a significant frequency in large population cohorts (Lek 2016, The 1000 Genomes Consortium 2015, NHLBI Exome Sequencing Project). Since Isoleucine and Asparagine differ in polarity, charge, size or other properties, this is considered a non-conservative amino acid substitution. MSH2 Ile648Asn occurs at a position that is not conserved and is located in the ATPase domain and region of interaction with EXO1 (Lützen 2008). In silico analyses predict that this variant is probably damaging to protein structure and function. Based on currently available evidence, it is unclear whether MSH2 Ile648Asn is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.
Invitae RCV000629936 SCV000750892 uncertain significance Hereditary nonpolyposis colon cancer 2018-10-15 criteria provided, single submitter clinical testing This sequence change replaces isoleucine with asparagine at codon 648 of the MSH2 protein (p.Ile648Asn). The isoleucine residue is weakly conserved and there is a large physicochemical difference between isoleucine and asparagine. This variant is present in population databases (rs763100088, ExAC 0.007%). This variant has been reported in a family affected with Lynch syndrome (PMID: 27601186). ClinVar contains an entry for this variant (Variation ID: 234021). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.